Genmab — Februar 2018

[Sukkeralf]

link

[Sukkeralf]

nice

[Teller]

gentogen : Ved du hvad market potential er inden for denne behandling?

[E_L]

nice indeed! that is the first trial in CLL, is it?

[E_L]

Ibrutinib still partly owned by Janssen JNJ, right?

[gentogen]

I tidsskriftet Blood var der i 2017 en artikel, der hed: Daratumumab Mitigates B-Cell Receptor Signaling and Enhances Antitumor Activity of Ibrutinib in Chronic Lymphocytic Leukemia (CLL) Cells, som netop understregede et i princippet stort potentiale

[gentogen]

Jeg har ingen ide om markedsmulighederne, men hvis ID virker endnu bedre end I, så vil jeg tro, at det er ganske stort. Det kan andre nok bedre vurdere

[Sukkeralf]

Det er også meget tidligt, så det skal vi nok ikke bekymre os om så meget indtil videre - ligeledes også blot et ISS

[Teller]

CLL er omkring 19000 nye diagnoser i US alene

[Teller]

Attention Required! | Cloudflare

(www.lls.org)

[Teller]

Side 6

[E_L]

and from the presentation i posted yesterday, p 18, CLL 36,000 US + G5

[E_L]

Don’t forget we will most likely get some warrants exercised this week and due to the jump in price we will get some employee sales

[E_L]

Nothing dramatic in the grand scheme of things. Newspapers will scream that Jan sold shares and repeat how much money he makes. We will argue about it for 2 days, as usual, and then slowly live will return back to normal until the next warrant expiry

[bibob]

Tror der er lidt afventende holdning til FED har talt i morgen. Det er jo en ny mand på posten. ( Powell)

[AaBforever]

Han har talt..bibob

[AaBforever]

I dag kl. 16..dansk tid

[AaBforever]

Ikke noget epokegørende nyt.

[E_L]

he is still talking mate...

[AaBforever]

Still no breaking news.